When Sperm Meets Egg, Meet the Robots: UCSF and Conceivable Automate IVF
Oct 26, 2026
To improve in vitro fertilization and fertility treatments, UC San Francisco and Conceivable Life Sciences have created a robotics, AI, and personalized embryology research center.
Read MoreTrop-2 Antibody-Drug Conjugate Improves Survival in Recurrent Endometrial Cancer
Oct 26, 2026Lung Cancer Blood Test May Help Predict Treatment Outcomes Before Surgery
Oct 26, 2026Brain Implant Could Prevent Glioblastoma Relapse with Ultrasound Drug Delivery
Oct 26, 2026Personalized mRNA Cancer Vaccine Cuts Melanoma Recurrence Risk by 42% in Phase III Trial
Oct 24, 2026Bispecific Immunotherapy Shows Early Activity in Treatment-Resistant Solid Tumors
Oct 23, 2026Blood Test Identifies Residual Cancer
Oct 21, 2026Engineered Albumin Improves Longevity and Delivery of Protein-Based Therapeutics
Oct 28, 2026
Early Research Shows How Postnatal Depression May Affect Offspring
Oct 27, 2026
Novo’s Answer to Retatrutide Does Well at Phase II in Type 2 Diabetes
Oct 26, 2026
Blood Test Could Identify Brain Injuries Missed by CT Scans
Oct 23, 2026
Next-Generation AI Agent Provides Personalized Health Advice
Oct 22, 2026
From Nobel to Nasdaq: Financing Nordic Precision Medicine’s Next Step
Oct 22, 2026
Informatics
Beyond Detection: Rethinking Radiology in the Age of AI
October 20, 2026While advances in artificial intelligence (AI) are opening up possibilities for how images are interpreted, reported, and acted upon, the challenge for healthcare systems lies…
Riaan’s Therapeutic Odyssey – Chapter 1: The Parents
September 03, 2026Riaan's family embarked on a journey to develop an experimental genetic therapy for his ultra-rare Cockayne syndrome, a condition with no existing treatment and a…
Can AI Agents Help the Right Patients Find the Right Trials?
October 20, 2026Clinical trials are generating increasingly large amounts of data, but companies are under immense pressure to complete trials quickly and under budget. Could agentic artificial…
Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
In this IPM webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology.
Surbhi Jain, PhD, MBBS
Staff Scientist
Bio-Rad Laboratories
Prithwish Pal, PhD
Director, Global Product Marketing – Oncology
Bio-Rad Laboratories
Rare Structural Mutations in NSCLC Successfully Targeted
Oct 21, 2026An early-phase trial found promising responses to firmonertinib in EGFR PACC-mutant NSCLC, highlighting how matching drug structure to mutation biology could expand targeted treatment options.
New PET Imaging Changes Care in Clear Cell Kidney Cancer
Oct 21, 2026A new CAIX-targeted PET imaging agent detected nearly all clear cell kidney cancer lesions, outperforming FDG PET and changing treatment decisions in more than one-third…
Hussam Al Kateb: Inside Mayo Clinic’s Molecular Diagnostic Revolution
Oct 21, 2026In this Behind the Breakthroughs, the Clinical Genomics Lab co-director discusses how gene fusion detection is raising the bar for precision oncology and cancer diagnostics…
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
Long QT Syndrome Risk Clarified by Functional Map of KCNQ1 Gene Variants
Digital Twins Identify Drug Combination to Prevent Preterm Birth
Preventive Cancer Vaccine Maker Nouscom Raises $135M and Presents Promising Lynch Syndrome Data
